Pharmacometabolomics is a subset of metabolomics, which is the science of quantifying and analyzing the metabolites found in biological samples. Pharmacometabolomics, which is rapidly gaining popularity, has already started to blossom in the sectors of drug development and personalised medicine, where it is already assisting in the development of major insights and the advancement of knowledge and product offerings in these fields. Pharmacometabolomics is a subset of metabolomics that focuses on analyzing metabolites to determine how individuals respond to therapy. Pharmacometabolomics can assist in identifying individuals or groups of persons who are most likely to respond to treatments. It can also help to identify those who are at risk of experiencing adverse side effects